Chemotherapy Induced Anemia Clinical Trial
Official title:
A Multicenter, Open-Label Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy
The purpose of this study is to evaluate the effectiveness and safety of recombinant human erythropoietin in anemic cancer patients undergoing chemotherapy.
n/a
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05301517 -
A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies
|
Phase 3 | |
Terminated |
NCT00931606 -
Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)
|
Phase 2 | |
Completed |
NCT00272662 -
Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy
|
Phase 2 | |
Not yet recruiting |
NCT06075030 -
A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy
|
Phase 2 | |
Completed |
NCT00144482 -
A Study of Recombinant Human Erythropoietin in Anemic Cancer Patients Undergoing Chemotherapy
|
Phase 3 | |
Completed |
NCT04076943 -
Evaluation of Efficacy and Safety of Roxadustat for the Treatment of Chemotherapy Induced Anemia
|
Phase 2 |